Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly “fit” patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi
暂无分享,去创建一个
P. Mazza | P. Gobbi | M. Federico | L. Baldini | F. Merli | G. Rossi | L. Marcheselli | F. Ilariucci | A. Liberati | A. Tucci | A. Rocco | A. Chiappella | S. Luminari | C. Stelitano | A. Arcari | F. Salvi | C. Mammi | M. Musso | A. Fragasso | I. Álvarez